Search results for "Scale down"
								 					Article
				
				Process Development: 2020 Reflections and 2021 Possibilities
								
	The challenges posed by the COVID-19 pandemic in 2020 brought about many unprecedented lessons and promising developments in the biopharmaceutical industry. Last year in particular reenforced the ne…								
								 					Article
				
				Akron Bio Will Install a Cytiva FlexFactory to Manufacture Plasmid DNA
								
	Cytiva will provide the first FlexFactory to be used in the manufacture of pDNA to Akron Bio. 
	
	Cytiva will provide its FlexFactory, a flexible, single-use platform, to enable Akron Biotech to m…								
								 					Article
				
				Improving mAb Manufacturing Productivity by Optimizing Buffer and Media Prep Process Flow
								
	Innovative approaches, including ready-to-use materials and in-line dilution, can significantly streamline overall bioprocessing operations.   
	By: Pranav Vengsarkar and Nandu Deorkar
	
		
			I…								
								 					Article
				
				Maximizing the Effectiveness of Upstream Bioprocessing Through the Combination of Lab Informatics and Instrumentation
								
	By establishing effective management of data and knowledge, it will be possible to employ advances, such as artificial intelligence and synthetic biology, to their full potential in upstream bioproc…								
								 					Poster
				
				Perfusion Media Development for Scalable Processes
								Cell culture perfusion processes are considered optimal for a truly integrated continuous biomanufacturing pipeline. The nutrient-rich but balanced media should be designed to support very low cell-sp…								
								 					Article
				
				Single-Use for Downstream Chromatography: Benefit or Hindrance?
								
	Single-use technology is gaining ground in downstream bioprocessing, but challenges stall further adoption.
	By Feliza Mirasol
	
	
	
	ARTMOIS/STOCK.ADOBE.COM
	
	Biopharmaceutical manufactu…								
								 					Article
				
				Scalable Viral Vector Manufacturing
								
	The interest for robust and scalable viral vector manufacturing is rapidly increasing, with the recent developments of both cell and gene therapy and oncolytic virus-based therapies. As cost pressur…								
								 					Article
				
				State of the Biopharmaceutical Industry: Lessons from 2018 Survey Data
								
	Since 2003, BioPlan Associates, Inc. of Rockville, MD, has surveyed developers of biotherapeutics and contract manufacturing organizations working in this space about current and projected capacity …								
								 					Article
				
				Ensuring Viral Safety of Viral Vaccines and Vectors
								Ensuring Viral Safety of Viral Vaccines and Vectors
	
		Viral vaccines and viral vectors used in biotherapeutic applications carry the risk of microbial contamination, which must be addressed. 
	
	
	…								
								 					Article
				
				The Challenge of Disruptive Technologies in Bioprocessing
								The Challenge of Disruptive Technologies in BioprocessingIncreasing demand for biologics is driving the need for innovation in bioprocessing. 
Jul 01, 2018 
Increasing demand for biologics is drivin…